This Week in Fraud is a peek into the world of whistleblowing and incentivized integrity programs. Each week we highlight important case settlements, industry developments, and general points of interest. Take a moment and see what is happening this week in fraud.
Taking the Penny Pledge is not only a way of showing support for whistleblowers – it’s also a way for law firms and whistleblowers to signal they are planning for success and are committed to making a real difference in this area of the law.
“Judge Kelly’s decision is not only a testament to Peggy’s commitment in this decade long case, but also reaffirms the value of all whistleblowers and the False Claims Act as the government’s most powerful tool in fighting fraud,” said James Hoyer Law Firm Managing Partner Chris Casper.
"We reject the Government’s argument for several reasons. First, the Government’s interpretation is contrary to the explicit language of the statute. The Court reads the statute to hold that the only measuring stick is the contribution of the relator. If Congress had intended limitations, like in the case of large awards, it would have explicitly included them within the statutory framework of the FCA. Congress’ silence on this issue compels rejection of the Government’s argument. Second, the Government has failed to include any legal precedent affirming this argument, and thorough research by this Court has failed to unearth any such support."
Joe Vincoli is a North Carolina whistleblower and public servant who has saved his state millions of dollars by pointing out examples of wasteful spending and lax oversight.
Late and secretive language was sneaked into the Wisconsin state budget that would kill the Wisconsin False Claims Act.
After a seven-year battle, pharmaceutical manufacturers AstraZeneca, Cephalon, and Biogen Idec have agreed to pay $55.5 million to settle a whistleblower-initiated False Claims Act case.